Violation of Licensing Agreement Revealed with In-Product Brand Protection Program The Issue An agricultural chemical manufacturer suspected that one of its formulators was in violation of a licensing agreement, substituting a generic active ingredient for the licensed component. The formulator also appeared to be diverting the end-product for sale in a region outside of its licensed territory where it had a higher value. The Solution The manufacturer turned to Authentix for a solution to ensure the use of their component in the formulator’s end-product. Authentix worked with the manufacturer to incorporate US FDA-compliant in-product markers into the licensed component, ensuring that the markers could endure the harsh synthesis process, become homogenous and remain stable, while not impac

Join for free to read